Skip to content

Body surface gastric mapping in patients with para-oesophageal hernias

A prospective pilot cohort study to investigate the utility and feasibility of using body surface gastric mapping (Gastric Alimetry) to assess gastric motility and function in patients who have undergone elective para-oesophageal hernia repair

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN18057434
Enrollment
20
Registered
2025-09-23
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Body surface gastric mapping in paraoesophageal hernia patients Digestive System

Interventions

Gastric Alimetry testing pre-operatively and between 3-6 months post-operatively The intervention in the current study is body surface gastric mapping (BSGM) measurement with the Alimetry device. BSGM

Sponsors

Oxford University Hospitals NHS Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Age over 18 years old 2. Elective para-oesophageal hernia repair (type of operation not specified) 3. Giant para-oesophageal hernia (defined by herniation of more than 50% of the stomach into the chest)

Exclusion criteria

Exclusion criteria: 1. BMI greater than 35 2. Unable to provide informed consent 3. Had previous para-oesophageal hernia repair or oesophago-gastric surgery 4. Diagnosis of an oesophago-gastric cancer 5. Emergency para-oesophageal hernia at presentation/surgery 6. Skin allergy or extreme sensitivity to cosmetics or lotions

Design outcomes

Primary

MeasureTime frame
Ease and use of body surface gastric mapping device measured using patient self-reported questionnaires at any point pre-operatively and repeated 3 to 6 months post-operatively

Secondary

MeasureTime frame
Captured electrical activity data measured using data from the device correlated with patient-reported outcomes measured using a Patient Reported Outcome Score Test (POST) and the Gastroesophageal Reflux Disease-Health Related Quality of Life (GORD-HRQL) questionnaires at any point pre-operatively and repeated 3 to 6 months post-operatively.

Countries

England, United Kingdom

Contacts

Public ContactWing Kiu Chou
kerry.chou@nhs.net+44 (0)300 304 7777

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026